ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biologics Clinical Manufacturing CDMO Service Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-7J15919
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biologics Clinical Manufacturing CDMO Service Market Research Report 2023
BUY CHAPTERS

Global Biologics Clinical Manufacturing CDMO Service Market Research Report 2025

Code: QYRE-Auto-7J15919
Report
May 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bio Rad
Element
ProPharma
Ascendia
Minaris Regenerative Medicine
TriLink BioTechnologies
Oakwood Labs
PiramalPharma Solutions
Boehringer Ingelheim
WuXi AppTec
Pharmaron Beijing
Asymchem Laboratories (Tianjin)
Porton
Seqens
Lonza
Thermo Fisher Scientific
Intertek
Charles River Laboratories

Biologics Clinical Manufacturing CDMO Service Market

The global market for Biologics Clinical Manufacturing CDMO Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Biologics Clinical Manufacturing CDMO Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Biologics Clinical Manufacturing CDMO Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Biologics Clinical Manufacturing CDMO Service in Big Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Biologics Clinical Manufacturing CDMO Service include Thermo Fisher Scientific, Lonza, Intertek, Charles River Laboratories, Bio-Rad, Element, ProPharma, Ascendia, Minaris Regenerative Medicine, TriLink BioTechnologies, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biologics Clinical Manufacturing CDMO Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics Clinical Manufacturing CDMO Service.
The Biologics Clinical Manufacturing CDMO Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biologics Clinical Manufacturing CDMO Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics Clinical Manufacturing CDMO Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Biologics Clinical Manufacturing CDMO Service Market Report

Report Metric Details
Report Name Biologics Clinical Manufacturing CDMO Service Market
Segment by Type
Segment by Application
  • Big Pharmaceutical Companies
  • Small and Medium Pharmaceutical Companies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Lonza, Intertek, Charles River Laboratories, Bio-Rad, Element, ProPharma, Ascendia, Minaris Regenerative Medicine, TriLink BioTechnologies, Oakwood Labs, PiramalPharma Solutions, Boehringer-Ingelheim, Wuxi Apptec, Pharmaron Beijing, Asymchem Laboratories (Tianjin), Porton, SEQENS
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Biologics Clinical Manufacturing CDMO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Biologics Clinical Manufacturing CDMO Service Market report?

Ans: The main players in the Biologics Clinical Manufacturing CDMO Service Market are Thermo Fisher Scientific, Lonza, Intertek, Charles River Laboratories, Bio-Rad, Element, ProPharma, Ascendia, Minaris Regenerative Medicine, TriLink BioTechnologies, Oakwood Labs, PiramalPharma Solutions, Boehringer-Ingelheim, Wuxi Apptec, Pharmaron Beijing, Asymchem Laboratories (Tianjin), Porton, SEQENS

What are the Application segmentation covered in the Biologics Clinical Manufacturing CDMO Service Market report?

Ans: The Applications covered in the Biologics Clinical Manufacturing CDMO Service Market report are Big Pharmaceutical Companies, Small and Medium Pharmaceutical Companies

What are the Type segmentation covered in the Biologics Clinical Manufacturing CDMO Service Market report?

Ans: The Types covered in the Biologics Clinical Manufacturing CDMO Service Market report are Traditional API CDMO, Highly Potent API CDMO

Recommended Reports

CDMO Market Services

Cell & Gene Therapy

Diagnostics & Testing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Traditional API CDMO
1.2.3 Highly Potent API CDMO
1.3 Market by Application
1.3.1 Global Biologics Clinical Manufacturing CDMO Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Big Pharmaceutical Companies
1.3.3 Small and Medium Pharmaceutical Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologics Clinical Manufacturing CDMO Service Market Perspective (2020-2031)
2.2 Global Biologics Clinical Manufacturing CDMO Service Growth Trends by Region
2.2.1 Global Biologics Clinical Manufacturing CDMO Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biologics Clinical Manufacturing CDMO Service Historic Market Size by Region (2020-2025)
2.2.3 Biologics Clinical Manufacturing CDMO Service Forecasted Market Size by Region (2026-2031)
2.3 Biologics Clinical Manufacturing CDMO Service Market Dynamics
2.3.1 Biologics Clinical Manufacturing CDMO Service Industry Trends
2.3.2 Biologics Clinical Manufacturing CDMO Service Market Drivers
2.3.3 Biologics Clinical Manufacturing CDMO Service Market Challenges
2.3.4 Biologics Clinical Manufacturing CDMO Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologics Clinical Manufacturing CDMO Service Players by Revenue
3.1.1 Global Top Biologics Clinical Manufacturing CDMO Service Players by Revenue (2020-2025)
3.1.2 Global Biologics Clinical Manufacturing CDMO Service Revenue Market Share by Players (2020-2025)
3.2 Global Biologics Clinical Manufacturing CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biologics Clinical Manufacturing CDMO Service Revenue
3.4 Global Biologics Clinical Manufacturing CDMO Service Market Concentration Ratio
3.4.1 Global Biologics Clinical Manufacturing CDMO Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics Clinical Manufacturing CDMO Service Revenue in 2024
3.5 Global Key Players of Biologics Clinical Manufacturing CDMO Service Head office and Area Served
3.6 Global Key Players of Biologics Clinical Manufacturing CDMO Service, Product and Application
3.7 Global Key Players of Biologics Clinical Manufacturing CDMO Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics Clinical Manufacturing CDMO Service Breakdown Data by Type
4.1 Global Biologics Clinical Manufacturing CDMO Service Historic Market Size by Type (2020-2025)
4.2 Global Biologics Clinical Manufacturing CDMO Service Forecasted Market Size by Type (2026-2031)
5 Biologics Clinical Manufacturing CDMO Service Breakdown Data by Application
5.1 Global Biologics Clinical Manufacturing CDMO Service Historic Market Size by Application (2020-2025)
5.2 Global Biologics Clinical Manufacturing CDMO Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biologics Clinical Manufacturing CDMO Service Market Size (2020-2031)
6.2 North America Biologics Clinical Manufacturing CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biologics Clinical Manufacturing CDMO Service Market Size by Country (2020-2025)
6.4 North America Biologics Clinical Manufacturing CDMO Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologics Clinical Manufacturing CDMO Service Market Size (2020-2031)
7.2 Europe Biologics Clinical Manufacturing CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biologics Clinical Manufacturing CDMO Service Market Size by Country (2020-2025)
7.4 Europe Biologics Clinical Manufacturing CDMO Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size (2020-2031)
8.2 Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologics Clinical Manufacturing CDMO Service Market Size (2020-2031)
9.2 Latin America Biologics Clinical Manufacturing CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biologics Clinical Manufacturing CDMO Service Market Size by Country (2020-2025)
9.4 Latin America Biologics Clinical Manufacturing CDMO Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologics Clinical Manufacturing CDMO Service Market Size (2020-2031)
10.2 Middle East & Africa Biologics Clinical Manufacturing CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biologics Clinical Manufacturing CDMO Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Biologics Clinical Manufacturing CDMO Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Biologics Clinical Manufacturing CDMO Service Introduction
11.1.4 Thermo Fisher Scientific Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Biologics Clinical Manufacturing CDMO Service Introduction
11.2.4 Lonza Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
11.2.5 Lonza Recent Development
11.3 Intertek
11.3.1 Intertek Company Details
11.3.2 Intertek Business Overview
11.3.3 Intertek Biologics Clinical Manufacturing CDMO Service Introduction
11.3.4 Intertek Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
11.3.5 Intertek Recent Development
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Details
11.4.2 Charles River Laboratories Business Overview
11.4.3 Charles River Laboratories Biologics Clinical Manufacturing CDMO Service Introduction
11.4.4 Charles River Laboratories Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
11.4.5 Charles River Laboratories Recent Development
11.5 Bio-Rad
11.5.1 Bio-Rad Company Details
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad Biologics Clinical Manufacturing CDMO Service Introduction
11.5.4 Bio-Rad Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
11.5.5 Bio-Rad Recent Development
11.6 Element
11.6.1 Element Company Details
11.6.2 Element Business Overview
11.6.3 Element Biologics Clinical Manufacturing CDMO Service Introduction
11.6.4 Element Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
11.6.5 Element Recent Development
11.7 ProPharma
11.7.1 ProPharma Company Details
11.7.2 ProPharma Business Overview
11.7.3 ProPharma Biologics Clinical Manufacturing CDMO Service Introduction
11.7.4 ProPharma Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
11.7.5 ProPharma Recent Development
11.8 Ascendia
11.8.1 Ascendia Company Details
11.8.2 Ascendia Business Overview
11.8.3 Ascendia Biologics Clinical Manufacturing CDMO Service Introduction
11.8.4 Ascendia Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
11.8.5 Ascendia Recent Development
11.9 Minaris Regenerative Medicine
11.9.1 Minaris Regenerative Medicine Company Details
11.9.2 Minaris Regenerative Medicine Business Overview
11.9.3 Minaris Regenerative Medicine Biologics Clinical Manufacturing CDMO Service Introduction
11.9.4 Minaris Regenerative Medicine Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
11.9.5 Minaris Regenerative Medicine Recent Development
11.10 TriLink BioTechnologies
11.10.1 TriLink BioTechnologies Company Details
11.10.2 TriLink BioTechnologies Business Overview
11.10.3 TriLink BioTechnologies Biologics Clinical Manufacturing CDMO Service Introduction
11.10.4 TriLink BioTechnologies Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
11.10.5 TriLink BioTechnologies Recent Development
11.11 Oakwood Labs
11.11.1 Oakwood Labs Company Details
11.11.2 Oakwood Labs Business Overview
11.11.3 Oakwood Labs Biologics Clinical Manufacturing CDMO Service Introduction
11.11.4 Oakwood Labs Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
11.11.5 Oakwood Labs Recent Development
11.12 PiramalPharma Solutions
11.12.1 PiramalPharma Solutions Company Details
11.12.2 PiramalPharma Solutions Business Overview
11.12.3 PiramalPharma Solutions Biologics Clinical Manufacturing CDMO Service Introduction
11.12.4 PiramalPharma Solutions Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
11.12.5 PiramalPharma Solutions Recent Development
11.13 Boehringer-Ingelheim
11.13.1 Boehringer-Ingelheim Company Details
11.13.2 Boehringer-Ingelheim Business Overview
11.13.3 Boehringer-Ingelheim Biologics Clinical Manufacturing CDMO Service Introduction
11.13.4 Boehringer-Ingelheim Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
11.13.5 Boehringer-Ingelheim Recent Development
11.14 Wuxi Apptec
11.14.1 Wuxi Apptec Company Details
11.14.2 Wuxi Apptec Business Overview
11.14.3 Wuxi Apptec Biologics Clinical Manufacturing CDMO Service Introduction
11.14.4 Wuxi Apptec Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
11.14.5 Wuxi Apptec Recent Development
11.15 Pharmaron Beijing
11.15.1 Pharmaron Beijing Company Details
11.15.2 Pharmaron Beijing Business Overview
11.15.3 Pharmaron Beijing Biologics Clinical Manufacturing CDMO Service Introduction
11.15.4 Pharmaron Beijing Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
11.15.5 Pharmaron Beijing Recent Development
11.16 Asymchem Laboratories (Tianjin)
11.16.1 Asymchem Laboratories (Tianjin) Company Details
11.16.2 Asymchem Laboratories (Tianjin) Business Overview
11.16.3 Asymchem Laboratories (Tianjin) Biologics Clinical Manufacturing CDMO Service Introduction
11.16.4 Asymchem Laboratories (Tianjin) Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
11.16.5 Asymchem Laboratories (Tianjin) Recent Development
11.17 Porton
11.17.1 Porton Company Details
11.17.2 Porton Business Overview
11.17.3 Porton Biologics Clinical Manufacturing CDMO Service Introduction
11.17.4 Porton Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
11.17.5 Porton Recent Development
11.18 SEQENS
11.18.1 SEQENS Company Details
11.18.2 SEQENS Business Overview
11.18.3 SEQENS Biologics Clinical Manufacturing CDMO Service Introduction
11.18.4 SEQENS Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
11.18.5 SEQENS Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Bio Rad
Element
ProPharma
Ascendia
Minaris Regenerative Medicine
TriLink BioTechnologies
Oakwood Labs
PiramalPharma Solutions
Boehringer Ingelheim
WuXi AppTec
Pharmaron Beijing
Asymchem Laboratories (Tianjin)
Porton
Seqens
Lonza
Thermo Fisher Scientific
Intertek
Charles River Laboratories
List of Tables
 Table 1. Global Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Traditional API CDMO
 Table 3. Key Players of Highly Potent API CDMO
 Table 4. Global Biologics Clinical Manufacturing CDMO Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Biologics Clinical Manufacturing CDMO Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Biologics Clinical Manufacturing CDMO Service Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Biologics Clinical Manufacturing CDMO Service Market Share by Region (2020-2025)
 Table 8. Global Biologics Clinical Manufacturing CDMO Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Biologics Clinical Manufacturing CDMO Service Market Share by Region (2026-2031)
 Table 10. Biologics Clinical Manufacturing CDMO Service Market Trends
 Table 11. Biologics Clinical Manufacturing CDMO Service Market Drivers
 Table 12. Biologics Clinical Manufacturing CDMO Service Market Challenges
 Table 13. Biologics Clinical Manufacturing CDMO Service Market Restraints
 Table 14. Global Biologics Clinical Manufacturing CDMO Service Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Biologics Clinical Manufacturing CDMO Service Market Share by Players (2020-2025)
 Table 16. Global Top Biologics Clinical Manufacturing CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Clinical Manufacturing CDMO Service as of 2024)
 Table 17. Ranking of Global Top Biologics Clinical Manufacturing CDMO Service Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Biologics Clinical Manufacturing CDMO Service Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Biologics Clinical Manufacturing CDMO Service, Headquarters and Area Served
 Table 20. Global Key Players of Biologics Clinical Manufacturing CDMO Service, Product and Application
 Table 21. Global Key Players of Biologics Clinical Manufacturing CDMO Service, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Biologics Clinical Manufacturing CDMO Service Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Biologics Clinical Manufacturing CDMO Service Revenue Market Share by Type (2020-2025)
 Table 25. Global Biologics Clinical Manufacturing CDMO Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Biologics Clinical Manufacturing CDMO Service Revenue Market Share by Type (2026-2031)
 Table 27. Global Biologics Clinical Manufacturing CDMO Service Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Biologics Clinical Manufacturing CDMO Service Revenue Market Share by Application (2020-2025)
 Table 29. Global Biologics Clinical Manufacturing CDMO Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Biologics Clinical Manufacturing CDMO Service Revenue Market Share by Application (2026-2031)
 Table 31. North America Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Biologics Clinical Manufacturing CDMO Service Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Biologics Clinical Manufacturing CDMO Service Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Biologics Clinical Manufacturing CDMO Service Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Biologics Clinical Manufacturing CDMO Service Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Biologics Clinical Manufacturing CDMO Service Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Biologics Clinical Manufacturing CDMO Service Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Biologics Clinical Manufacturing CDMO Service Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Biologics Clinical Manufacturing CDMO Service Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Thermo Fisher Scientific Company Details
 Table 47. Thermo Fisher Scientific Business Overview
 Table 48. Thermo Fisher Scientific Biologics Clinical Manufacturing CDMO Service Product
 Table 49. Thermo Fisher Scientific Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025) & (US$ Million)
 Table 50. Thermo Fisher Scientific Recent Development
 Table 51. Lonza Company Details
 Table 52. Lonza Business Overview
 Table 53. Lonza Biologics Clinical Manufacturing CDMO Service Product
 Table 54. Lonza Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025) & (US$ Million)
 Table 55. Lonza Recent Development
 Table 56. Intertek Company Details
 Table 57. Intertek Business Overview
 Table 58. Intertek Biologics Clinical Manufacturing CDMO Service Product
 Table 59. Intertek Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025) & (US$ Million)
 Table 60. Intertek Recent Development
 Table 61. Charles River Laboratories Company Details
 Table 62. Charles River Laboratories Business Overview
 Table 63. Charles River Laboratories Biologics Clinical Manufacturing CDMO Service Product
 Table 64. Charles River Laboratories Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025) & (US$ Million)
 Table 65. Charles River Laboratories Recent Development
 Table 66. Bio-Rad Company Details
 Table 67. Bio-Rad Business Overview
 Table 68. Bio-Rad Biologics Clinical Manufacturing CDMO Service Product
 Table 69. Bio-Rad Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025) & (US$ Million)
 Table 70. Bio-Rad Recent Development
 Table 71. Element Company Details
 Table 72. Element Business Overview
 Table 73. Element Biologics Clinical Manufacturing CDMO Service Product
 Table 74. Element Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025) & (US$ Million)
 Table 75. Element Recent Development
 Table 76. ProPharma Company Details
 Table 77. ProPharma Business Overview
 Table 78. ProPharma Biologics Clinical Manufacturing CDMO Service Product
 Table 79. ProPharma Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025) & (US$ Million)
 Table 80. ProPharma Recent Development
 Table 81. Ascendia Company Details
 Table 82. Ascendia Business Overview
 Table 83. Ascendia Biologics Clinical Manufacturing CDMO Service Product
 Table 84. Ascendia Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025) & (US$ Million)
 Table 85. Ascendia Recent Development
 Table 86. Minaris Regenerative Medicine Company Details
 Table 87. Minaris Regenerative Medicine Business Overview
 Table 88. Minaris Regenerative Medicine Biologics Clinical Manufacturing CDMO Service Product
 Table 89. Minaris Regenerative Medicine Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025) & (US$ Million)
 Table 90. Minaris Regenerative Medicine Recent Development
 Table 91. TriLink BioTechnologies Company Details
 Table 92. TriLink BioTechnologies Business Overview
 Table 93. TriLink BioTechnologies Biologics Clinical Manufacturing CDMO Service Product
 Table 94. TriLink BioTechnologies Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025) & (US$ Million)
 Table 95. TriLink BioTechnologies Recent Development
 Table 96. Oakwood Labs Company Details
 Table 97. Oakwood Labs Business Overview
 Table 98. Oakwood Labs Biologics Clinical Manufacturing CDMO Service Product
 Table 99. Oakwood Labs Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025) & (US$ Million)
 Table 100. Oakwood Labs Recent Development
 Table 101. PiramalPharma Solutions Company Details
 Table 102. PiramalPharma Solutions Business Overview
 Table 103. PiramalPharma Solutions Biologics Clinical Manufacturing CDMO Service Product
 Table 104. PiramalPharma Solutions Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025) & (US$ Million)
 Table 105. PiramalPharma Solutions Recent Development
 Table 106. Boehringer-Ingelheim Company Details
 Table 107. Boehringer-Ingelheim Business Overview
 Table 108. Boehringer-Ingelheim Biologics Clinical Manufacturing CDMO Service Product
 Table 109. Boehringer-Ingelheim Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025) & (US$ Million)
 Table 110. Boehringer-Ingelheim Recent Development
 Table 111. Wuxi Apptec Company Details
 Table 112. Wuxi Apptec Business Overview
 Table 113. Wuxi Apptec Biologics Clinical Manufacturing CDMO Service Product
 Table 114. Wuxi Apptec Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025) & (US$ Million)
 Table 115. Wuxi Apptec Recent Development
 Table 116. Pharmaron Beijing Company Details
 Table 117. Pharmaron Beijing Business Overview
 Table 118. Pharmaron Beijing Biologics Clinical Manufacturing CDMO Service Product
 Table 119. Pharmaron Beijing Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025) & (US$ Million)
 Table 120. Pharmaron Beijing Recent Development
 Table 121. Asymchem Laboratories (Tianjin) Company Details
 Table 122. Asymchem Laboratories (Tianjin) Business Overview
 Table 123. Asymchem Laboratories (Tianjin) Biologics Clinical Manufacturing CDMO Service Product
 Table 124. Asymchem Laboratories (Tianjin) Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025) & (US$ Million)
 Table 125. Asymchem Laboratories (Tianjin) Recent Development
 Table 126. Porton Company Details
 Table 127. Porton Business Overview
 Table 128. Porton Biologics Clinical Manufacturing CDMO Service Product
 Table 129. Porton Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025) & (US$ Million)
 Table 130. Porton Recent Development
 Table 131. SEQENS Company Details
 Table 132. SEQENS Business Overview
 Table 133. SEQENS Biologics Clinical Manufacturing CDMO Service Product
 Table 134. SEQENS Revenue in Biologics Clinical Manufacturing CDMO Service Business (2020-2025) & (US$ Million)
 Table 135. SEQENS Recent Development
 Table 136. Research Programs/Design for This Report
 Table 137. Key Data Information from Secondary Sources
 Table 138. Key Data Information from Primary Sources
 Table 139. Authors List of This Report


List of Figures
 Figure 1. Biologics Clinical Manufacturing CDMO Service Picture
 Figure 2. Global Biologics Clinical Manufacturing CDMO Service Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biologics Clinical Manufacturing CDMO Service Market Share by Type: 2024 VS 2031
 Figure 4. Traditional API CDMO Features
 Figure 5. Highly Potent API CDMO Features
 Figure 6. Global Biologics Clinical Manufacturing CDMO Service Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Biologics Clinical Manufacturing CDMO Service Market Share by Application: 2024 VS 2031
 Figure 8. Big Pharmaceutical Companies Case Studies
 Figure 9. Small and Medium Pharmaceutical Companies Case Studies
 Figure 10. Biologics Clinical Manufacturing CDMO Service Report Years Considered
 Figure 11. Global Biologics Clinical Manufacturing CDMO Service Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Biologics Clinical Manufacturing CDMO Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Biologics Clinical Manufacturing CDMO Service Market Share by Region: 2024 VS 2031
 Figure 14. Global Biologics Clinical Manufacturing CDMO Service Market Share by Players in 2024
 Figure 15. Global Top Biologics Clinical Manufacturing CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Clinical Manufacturing CDMO Service as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Biologics Clinical Manufacturing CDMO Service Revenue in 2024
 Figure 17. North America Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Biologics Clinical Manufacturing CDMO Service Market Share by Country (2020-2031)
 Figure 19. United States Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Biologics Clinical Manufacturing CDMO Service Market Share by Country (2020-2031)
 Figure 23. Germany Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Share by Region (2020-2031)
 Figure 31. China Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Biologics Clinical Manufacturing CDMO Service Market Share by Country (2020-2031)
 Figure 39. Mexico Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Biologics Clinical Manufacturing CDMO Service Market Share by Country (2020-2031)
 Figure 43. Turkey Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Biologics Clinical Manufacturing CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Thermo Fisher Scientific Revenue Growth Rate in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
 Figure 47. Lonza Revenue Growth Rate in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
 Figure 48. Intertek Revenue Growth Rate in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
 Figure 49. Charles River Laboratories Revenue Growth Rate in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
 Figure 50. Bio-Rad Revenue Growth Rate in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
 Figure 51. Element Revenue Growth Rate in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
 Figure 52. ProPharma Revenue Growth Rate in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
 Figure 53. Ascendia Revenue Growth Rate in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
 Figure 54. Minaris Regenerative Medicine Revenue Growth Rate in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
 Figure 55. TriLink BioTechnologies Revenue Growth Rate in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
 Figure 56. Oakwood Labs Revenue Growth Rate in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
 Figure 57. PiramalPharma Solutions Revenue Growth Rate in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
 Figure 58. Boehringer-Ingelheim Revenue Growth Rate in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
 Figure 59. Wuxi Apptec Revenue Growth Rate in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
 Figure 60. Pharmaron Beijing Revenue Growth Rate in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
 Figure 61. Asymchem Laboratories (Tianjin) Revenue Growth Rate in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
 Figure 62. Porton Revenue Growth Rate in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
 Figure 63. SEQENS Revenue Growth Rate in Biologics Clinical Manufacturing CDMO Service Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Biologics CDMO Market
Global Biologics CDMO Services Market Research Report 2024
Pharmaceutical CDMO Pharmaceutical Contract Development and Manufacturing Organization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Peptide CDMO Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cellular and Gene Therapy CDMO Market Research Report 2025
Global Cell Therapy CDMO Market Research Report 2025
Global Microbial CDMO Service Market Research Report 2024
Global Biologics Contract Manufacturing Market Research Report 2025
Global Mammalian CDMO Service Market Research Report 2024
Global CMO and CDMO biotechnology Market Research Report 2024
Global Cell and Gene Therapy CDMO Market Research Report 2024
Medical Device CDMO Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Contract Research Organization CRO and CDMO for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biopharmaceutical CDMO Service Market Research Report 2024
Global Gene Cell Therapy CDMO Market Research Report 2024
Global Innovative Drug CDMO Market Research Report 2024
Global Pharmaceutical Intermediate CDMO Market Research Report 2024
Global Cell and Gene Therapy CDMO Services Market Research Report 2024
Global Medical Device CDMO and CRO Market Research Report 2025
Global Plasmid CDMO Services Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions